A negative test result for certain BRCA2 gene mutations--which increase susceptibility to tumor growth--may not be an accurate indicator of a woman's lower risk for breast cancer.
Researchers on the lookout for ways to help detect one of the world's deadliest cancers may have a new biomarker on their hands. In lung cancer patients, scientists have linked the presence in tumors of the protein C4d to a higher cancer mortality rate, a new study says.
The environment that exists inside a person's intestines may impact the effectiveness of cancer therapy, according to new research by investigators at the National Cancer Institute and France's Gustave Roussy Institute.
Investigators at the University of Toronto say that the S100A7 protein can be used to flag precancerous oral lesions, precursors to cancer of the mouth, which is a particularly serious threat in Asia.
Lately, there's been a lot of scrutiny surrounding preclinical research. Last year, a former researcher at Amgen ($AMGN) found that many basic cancer studies--published in leading science...
While some investigators are seeking better ways to treat pancreatic cancer, others have been tracking biomarkers that can offer a more accurate way to identify the lethal disease earlier on, so patients can be treated while there's a greater chance of fighting the disease.
Pancreatic cancer has long remained one of the toughest targets in the oncology drug field. But an investigator says targeting a biomarker known as phosphatidylserine could greatly improve the odds of coming up with an effective therapy.
A compound derived from vegetables such as cabbage, cauliflower and broccoli may be able to protect cancer patients against the unpleasant and harmful effects of radiation therapy, according to a new study.
Breast cancer, the most common cancer in women, will kill about 40,000 patients this year, largely due to metastasis. But now, researchers may have a way to put the brakes on that process. A Danish team says it has zeroed in on a "molecular switch" that may help control metastases and could become a biomarker for diagnosing and treating cancer.
Quintiles, the world's largest CRO, has launched a study to determine whether preprofiling cancer patients for key biomarkers can ease trial enrollment and speed drug development.